Still some downside at AstraZeneca says Zak Mir
The new president has seemingly stolen a policy from his presidential rival Hillary Clinton, says Zak Mir, Tip TV’s technical analyst.
Astra has very important cancer drug trials underway with results due next year.
The price chart shows falls in October and November and with the main support level at £38 there may be a couple of pounds more on the downside before bargain hunters appear says Mir.
Quick facts: AstraZeneca
Market Cap: £93.5 billion
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE